Discovery Labs Plans Date With FDA On Surfaxin
This article was originally published in The Pink Sheet Daily
Executive Summary
$60 million financing deal will help bring first synthetic surfactant to market, firm says.
You may also be interested in...
Discovery Labs To Respond To Surfaxin “Approvable” Letter In September
Additional data must be collected on biological activity test, lipid-related impurities.
Discovery Labs To Respond To Surfaxin “Approvable” Letter In September
Additional data must be collected on biological activity test, lipid-related impurities.
Third Time’s Not A Charm: Discovery’s Surfaxin Receives “Approvable” Letter
Synthetic surfactant for prevention of respiratory distress syndrome in premature infants is deemed “approvable” by FDA.